194 Results

  1. 2006
  2. Published

    Nascent entrepreneurs in German regions: evidence from the Regional Entrepreneurship Monitor (REM)

    Liickgen, I., Oberschachtsiek, D., Sternberg, R. & Wagner, J., 2006, International Studies in Entrepreneurship. Boston, p. 7-34 28 p. (International Studies in Entrepreneurship; vol. 14).

    Research output: Chapter in book/report/conference proceedingContribution to book/anthologyResearchpeer review

  3. 2005
  4. Published

    Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany

    Kulp, W., Graf Von Der Schulenburg, J. M. & Greiner, W., Dec 2005, In: European Journal of Health Economics. 6, 4, p. 317-321 5 p.

    Research output: Contribution to journalArticleResearchpeer review

  5. Published

    Letter from the Editors

    Von Der Schulenburg, J. M. G. & Greiner, W., Dec 2005, In: European Journal of Health Economics. 6, 4, p. 284 1 p.

    Research output: Contribution to journalEditorial in journalResearchpeer review

  6. German health care system in transition: The difficult way to balance cost containment and solidarity

    Graf Von Der Schulenburg, J. M., Jun 2005, In: European Journal of Health Economics. 6, 2, p. 183-187 5 p.

    Research output: Contribution to journalReview articleResearchpeer review

  7. Intermediation in innovation

    Hoppe, H. C. & Ozdenoren, E., Jun 2005, In: International Journal of Industrial Organization. 23, 5-6, p. 483-503 21 p.

    Research output: Contribution to journalArticleResearchpeer review

  8. Published

    Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon α-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany

    Siebert, U., Sroczynski, G., Wasem, J., Greiner, W., Ravens-Sieberer, U., Aidelsburger, P., Kurth, B. M., Bullinger, M., Graf Von Der Schulenburg, J. M., Wong, J. B. & Rossol, S., Jun 2005, In: European Journal of Health Economics. 6, 2, p. 112-123 12 p.

    Research output: Contribution to journalArticleResearchpeer review

  9. Published

    Validating the EQ-5D with time trade off for the German population

    Greiner, W., Claes, C., Busschbach, J. J. V. & Graf Von Der Schulenburg, J. M., Jun 2005, In: European Journal of Health Economics. 6, 2, p. 124-130 7 p.

    Research output: Contribution to journalArticleResearchpeer review

  10. Corporate Venture Capital Organizations in Germany: A Comparison

    Weber, C. & Weber, B., 2005, International Studies in Entrepreneurship. Springer, p. 127-156 30 p. (International Studies in Entrepreneurship; vol. 10).

    Research output: Chapter in book/report/conference proceedingContribution to book/anthologyResearchpeer review

  11. 2004
  12. Published

    Comparison of estimated medical costs among patients who are defined as having rheumatoid arthritis using three different standards

    Ruof, J., Hülsemann, J. L., Mittendorf, T., Handelmann, S., Aultman, R., Von Der Schulenburg, J. M., Zeidler, H. & Merkesdal, S., Feb 2004, In: European Journal of Health Economics. 5, 1, p. 64-69 6 p.

    Research output: Contribution to journalReview articleResearchpeer review

  13. 2003
  14. Published

    Economic evaluation of human papillomavirus screening in Germany

    Mittendorf, T., Petry, K. U., Iftner, T., Greiner, W. & Von der Schulenburg, J. M., Sept 2003, In: European Journal of Health Economics. 4, 3, p. 209-215 7 p.

    Research output: Contribution to journalArticleResearchpeer review

  15. Published

    Implementing standardized cost categories within economic evaluations in musculoskeletal diseases

    Mittendorf, T., Merkesdal, S., Huelsemann, J. L., Von der Schulenburg, J. M., Zeidler, H. & Ruof, J., Mar 2003, In: European Journal of Health Economics. 4, 1, p. 43-49 7 p.

    Research output: Contribution to journalArticleResearchpeer review

  16. Published

    The fourth hurdle as controlling instrument for expenditure on medication?

    Kulp, W., Greiner, W. & Von der Schulenburg, J. M., Mar 2003, In: European Journal of Health Economics. 4, 1, p. 1-5 5 p.

    Research output: Contribution to journalEditorial in journalResearchpeer review

  17. 2002
  18. Published

    Commentary: On Drummond’s “Time for a change in drug licensing requirements?“

    Drummond, M. F. & Von der Schulenburg, J. M. G., Jun 2002, In: European Journal of Health Economics. 3, 2, p. 137-139 3 p.

    Research output: Contribution to journalCommentary in journalResearchpeer review

  19. 2000
  20. Second-mover advantages in the strategic adoption of new technology under uncertainty

    Hoppe, H. C., Feb 2000, In: International Journal of Industrial Organization. 18, 2, p. 315-338 24 p.

    Research output: Contribution to journalArticleResearchpeer review

Previous 1...6 7 8 9 10 Next